EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Lymph node targeting nanomedicines for tumor immunotherapy

Xiaotong Li, Ruiyin Cheng, Deng Junyi, Yuchun Wu, Liangqing Ou, Ting Yan, Xuan Zhou, Zhishan Liu, Shaomei Feng, Lei Chen, Rui Yu, Shiying Li

Biomaterials · 2026

DOI: 10.1016/j.biomaterials.2025.123735 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomaterials, 2026. Verfasst von Xiaotong Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, 510630, China. Hauptthemen laut MEDLINE: Immunotherapy, Neoplasms, Lymph Nodes, Nanomedicine. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 227 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lymph nodes (LNs) are central hubs of adaptive immunity, orchestrating T cell activation and long-term immune surveillance, making them prime targets for cancer immunotherapy. However, their inherent immunosuppressive microenvironment and the systemic distribution of conventional therapies often limit antitumor efficacy and increase off-target toxicity. LN-targeted nanomedicines offer a promising strategy to overcome these limitations by enhancing antigen presentation, activating T cells within LNs, and reversing immunosuppression, while minimizing systemic exposure. Key strategies for LN targeting include: (1) passive targeting, where nanoparticle size, charge, and deformability are optimized to favor lymphatic uptake and LN accumulation; (2) active targeting, leveraging ligand-receptor interactions to selectively engage LN-resident immune cells or lymphatic structures; and (3) controlled drug release, enabling sustained and localized delivery to potentiate immunomodulatory effects. This review examines the immunosuppressive LN microenvironment and the barriers to effective nanomedicine delivery, then provides a comprehensive overview of LN-targeted nanomedicine designs, highlighting functional optimization strategies. By integrating mechanistic insights and design principles, we outline future directions for developing LN-targeted immunotherapies that enhance antitumor immunity, promote durable memory responses, and improve clinical translatability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyNeoplasmsLymph NodesNanomedicineHumansAnimalsNanoparticlesDrug Delivery SystemsTumor Microenvironment

Stichwörter der Autor:innen

Drug deliveryLymph node targetingNanomedicineTumor immunotherapy

Autor:innen und Institutionen

  • Department of Anesthesiology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, 510630, China.
  • Department of Anesthesiology, The Second Clinical School of Guangzhou Medical University, Guangzhou, 511436, China.
  • Department of Clinical Medicine, The Third Clinical School of Guangzhou Medical University, Guangzhou, 511436, China.
  • State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzho…
  • State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou, 510006, China.
  • Department of Anesthesiology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, China.

Zitieren

APA

Li, X., Cheng, R., Junyi, D., Wu, Y., Ou, L., Yan, T., Zhou, X., Liu, Z., Feng, S., Chen, L., Yu, R., & Li, S. (2026). Lymph node targeting nanomedicines for tumor immunotherapy. Biomaterials. https://doi.org/10.1016/j.biomaterials.2025.123735

Vancouver

Li X, Cheng R, Junyi D, Wu Y, Ou L, Yan T, et al. Lymph node targeting nanomedicines for tumor immunotherapy. Biomaterials. 2026. doi:10.1016/j.biomaterials.2025.123735

BibTeX
@article{Li2026,
  author = {Li, Xiaotong and Cheng, Ruiyin and Junyi, Deng and Wu, Yuchun and Ou, Liangqing and Yan, Ting and Zhou, Xuan and Liu, Zhishan and Feng, Shaomei and Chen, Lei and Yu, Rui and Li, Shiying},
  title = {Lymph node targeting nanomedicines for tumor immunotherapy},
  journal = {Biomaterials},
  year = {2026},
  doi = {10.1016/j.biomaterials.2025.123735}
}
Kostenlos starten →